Global Patent Index - EP 1003859 A1

EP 1003859 A1 2000-05-31 - USE OF TRANSCRIPTION FACTOR BRN-3A

Title (en)

USE OF TRANSCRIPTION FACTOR BRN-3A

Title (de)

VERWENDUNG VON TRANSKRIPTIONSFAKTOR BRN-3A

Title (fr)

UTILISATION DU FACTEUR DE TRANSCRIPTION BRN-3A

Publication

EP 1003859 A1 (EN)

Application

EP 98936506 A

Priority

  • GB 9802228 W
  • GB 9715823 A
  • US 98847697 A

Abstract (en)

[origin: WO9905272A1] The present invention provides a polypeptide comprising transcription factor Brn-3a or a derivative thereof for use in a method of treatment of the human or animal body by therapy.

IPC 1-7 (main, further and additional classification)

C12N 15/12; A61K 38/17; A61K 39/245; A61K 48/00; C07K 14/47; C12N 7/00; C12N 15/86

IPC 8 full level (invention and additional information)

C12N 15/09 (2006.01); A61K 38/17 (2006.01); A61K 39/245 (2006.01); A61K 48/00 (2006.01); A61P 25/00 (2006.01); C07K 14/47 (2006.01); C12N 7/00 (2006.01); C12N 15/12 (2006.01); A61K 38/00 (2006.01)

CPC (invention and additional information)

C07K 14/4705 (2013.01); A61K 38/00 (2013.01); A61K 48/00 (2013.01); C12N 2799/028 (2013.01)

Citation (search report)

See references of WO 9905272A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

WO 9905272 A1 19990204; WO 9905272 A9 19991028; AU 8548198 A 19990216; CA 2298107 A1 19990204; EP 1003859 A1 20000531; IL 134210 D0 20010430; JP 2001511344 A 20010814

INPADOC legal status


2003-08-27 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20030201

2001-03-21 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: BIOVEX LIMITED

2000-09-13 [RAP1] TRANSFER OF RIGHTS OF AN EP PUBLISHED APPLICATION

- Owner name: BIOVEX LIMITED

2000-05-31 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20000223

2000-05-31 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE